8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): January 31, 2019

KEMET Corporation

(Exact name of registrant as specified in its charter)

Delaware	001-15491	57-0923789
(State of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

KEMET Tower, One East Broward Blvd., Fort Lauderdale, Florida	33301
(Address of principal executive offices)	(Zip Code)

(954) 766-2800

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

-------------------------------------------------------------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Item 2.02 Results of Operations and Financial Condition

On January 31, 2019, KEMET Corporation (the “Company”) issued a News Release announcing preliminary consolidated results for the third fiscal quarter ended December 31, 2018.

A copy of this News Release is furnished as Exhibit 99.1 to this Form 8-K.

Item 7.01 Regulation FD Disclosure

On January 31, 2019, the Company will host a conference call to discuss financial results for its third fiscal quarter ended December 31, 2018.  The slide package prepared for use by executive management for this presentation is attached hereto as Exhibit 99.2.  All of the information in the presentation is presented as of January 31, 2019, and the Company does not assume any obligation to update such information in the future.

The information included in this Form 8-K, as well as Exhibits 99.1 and 99.2, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.

Item 9.01 Financial Statements and Exhibits

(a) Not Applicable

(b) Not Applicable

(c) Not Applicable

(d) Exhibits

Exhibit No.	Description of Exhibit
99.1	News Release, dated January 31, 2019 issued by the Company.
99.2	Slide Package prepared for use in connection with the Company’s third fiscal quarter conference call to be held on January 31, 2019.

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:	January 31, 2019	KEMET Corporation
	By:	/s/ GREGORY C. THOMPSON
		Gregory C. Thompson
		Executive Vice President and
		Chief Financial Officer

EX-99.1

News Release

Exhibit 99.1

FOR IMMEDIATE RELEASE

Contact:	Gregory C. Thompson	Richard Vatinelle
	Executive Vice President and	Vice President and
	Chief Financial Officer	Treasurer
	GregThompson@KEMET.com	InvestorRelations@KEMET.com
	954-595-5081	954-766-2819

KEMET REPORTS PRELIMINARY FISCAL 2019THIRD QUARTER RESULTS

• Net sales of $350.2 millionup14.2% versus prior year third fiscal quarter

• GAAP Diluted EPS up more than 100% versus prior year third fiscal quarter

• GAAP EPS of $0.69 per diluted share and Non-GAAP Adjusted EPS of $1.07 per diluted share

• GAAP Gross margin of 35.3% up 520 basis points versus prior year third quarter

Fort Lauderdale, Florida (January 31, 2019) - KEMET Corporation (“KEMET” or the “Company”) (NYSE: KEM), a leading global supplier of passive electronic components, today reported preliminary results for its third fiscal quarter ended December 31, 2018.

Net sales of $350.2 million for the quarter ended December 31, 2018increased$1.0 million, or 0.3%, from net sales of $349.2 million for the prior quarter ended September 30, 2018. Net sales increased$43.6 million, or 14.2% from net sales of $306.6 million for the quarter ended December 31, 2017.

“We are pleased with the strong operational performance in our third quarter with gross margins increasing to 35.3%, primarily due to a significant improvement in the Solid Capacitor segment. Looking forward we see continued strength in our Ceramic products, along with further improvement driven by our capital investments. The recently announced ten-year customer financed capacity agreements totaling $66 million to date and resulting new KEMET capacity will further enhance this growth,” stated William Lowe, the Company's Chief Executive Officer. “We expect these positive trends to continue along with growth in several of our key markets, which should offset some of the recent weakness in certain consumer markets and in Asia,” continued Mr. Lowe.

U.S. GAAP net income was $40.8 million or $0.69 per diluted share for the quarter ended December 31, 2018, compared to U.S. GAAP net income of $37.1 million or $0.63 per diluted share for the quarter ended September 30, 2018. For the quarter ended December 31, 2017, the Company reported a U.S. GAAP net income of $18.6 million or $0.32 per diluted share.

Non-GAAP adjusted net income was $63.1 million or $1.07 per diluted share for the quarter ended December 31, 2018, compared to non-GAAP adjusted net income of $51.3 million or $0.87 per diluted share for the quarter ended September 30, 2018. For the quarter ended December 31, 2017, the Company reported non-GAAP adjusted net income of $30.6 million or $0.52 per diluted share.

Net income (loss) for the quarters ended December 31, 2018, September 30, 2018 and December 31, 2017 include various items affecting comparability as denoted in the U.S. GAAP to non-GAAP reconciliation table included hereafter.

About KEMET

The Company’s common stock is listed on the NYSE under the ticker symbol “KEM” (NYSE: KEM).  At the Investor Relations section of our web site at http://www.kemet.com/IR, users may subscribe to KEMET news releases and find additional information about our Company.  KEMET offers our customers the broadest selection of capacitor technologies in the industry, along with an expanding range of electromechanical devices, electromagnetic compatibility solutions and supercapacitors. Our vision is to be the preferred supplier of electronic component solutions demanding the highest standards of quality, delivery and service. Additional information about KEMET can be found at http://www.kemet.com.

Quiet Period

Beginning January 1, 2019, we will observe a quiet period during which the information provided in this news release and quarterly report on Form 10-Q will no longer constitute our current expectations. During the quiet period, this information should be considered to be historical, applying prior to the quiet period only and not subject to update by management. The quiet period will extend until the day when our next quarterly earnings release is published.

Cautionary Statement on Forward-Looking Statements

Certain statements included herein contain forward-looking statements within the meaning of federal securities laws about the Company's financial condition and results of operations that are based on management's current expectations, estimates and projections about the markets, in which the Company operates, as well as management's beliefs and assumptions. Words such as "expects," "anticipates," "believes," "estimates" or other similar expressions and future or conditional verbs such as “will,” “should,” “would,” and “could” are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in, or implied by, such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's judgment only as of the date hereof. The Company undertakes no obligation to update publicly any of these forward-looking statements to reflect new information, future events or otherwise.

Factors that may cause actual outcomes and results to differ materially from those expressed in, or implied by, these forward-looking statements include, but are not necessarily limited to the following: (i) adverse economic conditions could impact our ability to realize operating plans if the demand for our products declines, and such conditions could adversely affect our liquidity and ability to continue to operate and could cause a write down of long-lived assets or goodwill; (ii) an increase in the cost or a decrease in the availability of our principal or single-sourced purchased raw materials; (iii) changes in the competitive environment; (iv) uncertainty of the timing of customer product qualifications in heavily regulated industries; (v) economic, political, or regulatory changes in the countries in which we operate; (vi) difficulties, delays, or unexpected costs in completing the Company’s restructuring plans; (vii) acquisitions and other strategic transactions expose us to a variety of risks, including the ability to successfully integrate and maintain adequate internal controls over financial reporting in compliance with applicable regulations; (viii) our acquisition of TOKIN Corporation may not achieve all of the anticipated results; (ix) our business could be negatively impacted by increased regulatory scrutiny and litigation; (x) difficulties associated with retaining, attracting, and training effective employees and management; (xi) the need to develop innovative products to maintain customer relationships and offset potential price erosion in older products; (xii) exposure to claims alleging product defects; (xiii) the impact of laws and regulations that apply to our business, including those relating to environmental matters, data protection, cyber security and privacy; (xiv) the impact of international laws relating to trade, export controls and foreign corrupt practices; (xv) changes impacting international trade and corporate tax provisions related to the global manufacturing and sales of our products may have an adverse effect on our financial condition and results of operations; (xvi) volatility of financial and credit markets affecting our access to capital; (xvii) the need to reduce the total costs of our products to remain competitive; (xviii) potential limitation on the use of net operating losses to offset possible future taxable income; (xix) restrictions in our debt agreements that could limit our flexibility in operating our business; (xx) disruption to our information technology systems to function properly or control unauthorized access to our systems may cause business disruptions; (xxi) economic and demographic experience for pension and other post-retirement benefit plans could be less favorable than our assumptions; (xxii) fluctuation in distributor sales could adversely affect our results of operations; (xxiii) earthquakes and other natural disasters could disrupt our operations and have a material adverse effect on our financial condition and results of operations; and (xxiv) volatility in our stock price.

2

KEMET CORPORATION AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(Amounts in thousands, except per share data)

(Unaudited)

	Quarters Ended December 31,
	2018			2017
Net sales (1)	$	350,175		$	306,576
Operating costs and expenses:
Cost of sales (1)	226,425			214,288
Selling, general and administrative expenses	48,271			47,751
Research and development (1)	11,357			9,907
Restructuring charges	1,718			3,530
(Gain) loss on write down and disposal of long-lived assets	788			(902		)
Total operating costs and expenses (1)	288,559			274,574
Operating income (loss) (1)	61,616			32,002
Non-operating (income) expense:
Interest income	(572		)	(252		)
Interest expense	4,480			7,407
Acquisition (gain) loss	—			(310		)
Other (income) expense, net	14,006			4,769
Income (loss) before income taxes and equity income (loss) from equity method investments (1)	43,702			20,388
Income tax expense (benefit) (1)	2,600			2,037
Income (loss) before equity income (loss) from equity method investments (1)	41,102			18,351
Equity income (loss) from equity method investments	(296		)	238
Net income (loss) (1)	$	40,806		$	18,589
Net income (loss) per basic share	$	0.70		$	0.33
Net income (loss) per diluted share	$	0.69		$	0.32
Dividends declared per share	$	0.05		$	—
Weighted-average shares outstanding:
Basic	58,010			56,778
Diluted	59,111			58,937

_________________

⁽¹⁾ Quarter ended December 31, 2017 adjusted due to the adoption of ASC 606, Revenue from Contracts with Customers ("ASC 606").

3

KEMET CORPORATION AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(Amounts in thousands, except per share data)

(Unaudited)

	December 31, 2018			March 31, 2018
ASSETS
Current assets:
Cash and cash equivalents	$	234,359		$	286,846
Accounts receivable, net (1)	147,848			146,561
Inventories, net	233,337			204,386
Prepaid expenses and other current assets	40,294			41,160
Total current assets  (1)	655,838			678,953
Property, plant and equipment, net of accumulated depreciation of $867,313 and $866,614 as of December 31, 2018 and March 31, 2018, respectively	438,265			405,316
Goodwill	40,294			40,294
Intangible assets, net	55,170			59,907
Equity method investments	12,861			12,016
Deferred income taxes	11,722			13,837
Other assets (1)	17,107			12,600
Total assets (1)	$	1,231,257		$	1,222,923
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current portion of long-term debt	$	28,416		$	20,540
Accounts payable	144,418			139,989
Accrued expenses (1)	98,279			125,119
Income taxes payable	3,684			2,010
Total current liabilities (1)	274,797			287,658
Long-term debt	277,260			304,083
Other non-current obligations(1)	125,856			152,249
Deferred income taxes (1)	14,911			15,058
Total liabilities (1)	692,824			759,048
Stockholders’ equity:
Preferred stock, par value $0.01, authorized 10,000 shares, none issued	—			—
Common stock, par value $0.01, authorized 175,000 shares, issued 57,819 and 56,641 shares at December 31, 2018 and March 31, 2018, respectively	578			566
Additional paid-in capital	462,882			462,737
Retained earnings (1)	113,664			3,370
Accumulated other comprehensive income (loss) (1)	(38,691		)	(2,798		)
Total stockholders’ equity (1)	538,433			463,875
Total liabilities and stockholders’ equity  (1)	$	1,231,257		$	1,222,923

_________________

⁽¹⁾ Year ended March 31, 2018 adjusted due to the adoption of ASC 606.

4

KEMET CORPORATION AND SUBSIDIARIES

Condensed Consolidated Statements of Cash Flows

(Amounts in thousands)

(Unaudited)

	Nine months ended December 31,
Operating Activities:	2018			2017
Net income (loss) (1)	$	113,167		$	251,847
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities, net of effect of acquisitions:
Depreciation and amortization (1)	38,405			37,366
Equity (income) loss from equity method investments	301			(75,879		)
Acquisition (gain) loss	—			(137,183		)
Non-cash debt and financing costs	1,085			1,820
(Gain) loss on early extinguishment of debt	15,988			486
Stock-based compensation expense	10,011			4,837
Receivable write down	84			162
(Gain) loss on write down and disposal of long-lived assets	1,611			(922		)
Pension and other post-retirement benefits	3,823			3,897
Change in deferred income taxes (1)	1,395			(3,792		)
Change in operating assets (1)	(42,130		)	25,820
Change in operating liabilities (1)	(61,485		)	(26,258		)
Other (1)	472			582
Net cash provided by (used in) operating activities (1)	82,727			82,783
Investing activities:
Capital expenditures	(77,650		)	(30,925		)
Acquisitions, net of cash received	—			167,129
Proceeds from sale of assets	169			1,227
Proceeds from dividend	776			2,731
Contributions to equity method investments	(2,000		)	—
Net cash provided by (used in) investing activities	(78,705		)	140,162
Financing activities:
Payments on revolving line of credit	—			(33,881		)
Payments of long-term debt	(332,063		)	(361,625		)
Proceeds from issuance of debt	293,348			334,978
Early extinguishment of debt costs	(3,234		)	—
Debt issuance costs	(1,797		)	(5,002		)
Proceeds from exercise of stock warrants	—			8,838
Proceeds from exercise of stock options	480			5,122
Payment of dividends	(2,873		)	—
Net cash provided by (used in) financing activities	(46,139		)	(51,570		)
Net increase (decrease) in cash, cash equivalents and restricted cash	(42,117		)	171,375
Effect of foreign currency fluctuations on cash, cash equivalents and restricted cash (1)	(7,236		)	3,017
Cash, cash equivalents, and restricted cash, at beginning of fiscal period	286,846			109,774
Cash, cash equivalents, and restricted cash, at end of fiscal period	237,493			284,166
Less: Restricted cash at end of period	3,134			—
Cash and cash equivalents at end of period	$	234,359		$	284,166

_________________

5

⁽¹⁾Nine Months Ended December 31, 2017 adjusted due to the adoption of ASC 606.

6

Non-GAAP Financial Measures

The Company utilizes certain Non-GAAP financial measures, including “Adjusted gross margin”, “Adjusted operating income (loss)”, “Adjusted net income (loss)”, “Adjusted net income (loss) per basic and diluted share” and “Adjusted EBITDA”.  Management believes that investors may find it useful to review the Company’s financial results as adjusted to exclude items as determined by management as further described below.

Adjusted Gross Margin

Adjusted gross margin represents net sales less cost of sales excluding adjustments which are outlined in the quantitative reconciliation provided below.  Management uses adjusted gross margin to facilitate our analysis and understanding of our business operations by excluding the items outlined in the quantitative reconciliation provided below which might otherwise make comparisons of our ongoing business with prior periods more difficult and obscure trends in ongoing operations. The Company believes that adjusted gross margin is useful to investors because it provides a supplemental way to understand the underlying operating performance of the Company.  Adjusted gross margin should not be considered as an alternative to gross margin or any other performance measure derived in accordance with U.S. GAAP.

The following table provides reconciliation from U.S. GAAP Gross margin to Non-GAAP Adjusted gross margin (amounts in thousands, except percentages):

	Quarters Ended
	(Unaudited)
	December 31, 2018			September 30, 2018			December 31, 2017
Net sales (1)	$	350,175		$	349,233		$	306,576
Cost of sales (1)	226,425			235,668			214,288
Gross margin (U.S. GAAP) (1)	123,750			113,565			92,288
Gross margin as a % of net sales	35.3		%	32.5		%	30.1		%
Non-GAAP adjustments:
Stock-based compensation expense	666			686			402
Plant start-up costs	305			1,361			—
Adjusted gross margin (non-GAAP) (1)	$	124,721		$	115,612		$	92,690
Adjusted gross margin as a % of net sales (non-GAAP)	35.6		%	33.1		%	30.2		%

_________________

⁽¹⁾ Quarter ended December 31, 2017 adjusted due to the adoption of ASC 606.

7

Adjusted Operating Income (Loss)

Adjusted operating income (loss) represents operating income (loss), excluding adjustments which are outlined in the quantitative reconciliation provided below. We use Adjusted operating income (loss) to facilitate our analysis and understanding of our business operations by excluding the items outlined in the quantitative reconciliation provided below, which might otherwise make comparisons of our ongoing business with prior periods more difficult and obscure trends in ongoing operations. The Company believes that Adjusted operating income (loss) is useful to investors to provide a supplemental way to understand our underlying operating performance and allows investors to monitor and understand changes in our ability to generate income from ongoing business operations. Adjusted operating income (loss) should not be considered as an alternative to operating income (loss) or any other performance measure derived in accordance with U.S. GAAP.

Adjusted operating income (loss) is calculated as follows (amounts in thousands):

	Quarters Ended
	(Unaudited)
	December 31, 2018		September 30, 2018		December 31, 2017
Operating income (loss) (U.S. GAAP) (1)	$	61,616	$	50,000	$	32,002
Non-GAAP adjustments:
Restructuring charges	1,718		—		3,530
ERP integration/IT transition costs	2,453		1,593		—
Stock-based compensation expense	1,534		4,417		2,206
Legal expenses/fines related to antitrust class actions	1,268		1,740		1,482
Plant start-up costs	305		1,361		—
(Gain) loss on write down and disposal of long-lived assets	788		312		(902		)
Adjusted operating income (loss) (non-GAAP)	$	69,682	$	59,423	$	38,318

_________________

⁽¹⁾ Quarter ended December 31, 2017 adjusted due to the adoption of ASC 606.

Adjusted Net Income (Loss) and Adjusted Net Income (Loss) Per Share

“Adjusted net income (loss)” and “Adjusted net income (loss) per basic and diluted share” represent net income (loss) and net income (loss) per basic and diluted share excluding adjustments which are outlined in the quantitative reconciliation provided below.  The Company believes that these Non-GAAP financial measures are useful to investors because they provide a supplemental way to understand the underlying operating performance of the Company and allows investors to monitor and understand changes in our ability to generate income from ongoing business operations.  Management uses these Non-GAAP financial measures to evaluate operating performance by excluding the items outlined in the quantitative reconciliation provided earlier in this presentation which might otherwise make comparisons of our ongoing business with prior periods more difficult and obscure trends in ongoing operations. Non-GAAP financial measures should not be considered as an alternative to net income (loss), operating income (loss) or any other performance measures derived in accordance with U.S. GAAP.

8

The following table provides reconciliation from U.S. GAAP net income (loss) to Non-GAAP Adjusted net income (loss) (amounts in thousands, except per share data):

	Quarters Ended
	(Unaudited)
	December 31, 2018			September 30, 2018			December 31, 2017
U.S. GAAP
Net sales (1)	$	350,175		$	349,233		$	306,576
Net income (loss) (1)	$	40,806		$	37,141		$	18,589
Net income (loss) per basic share	$	0.70		$	0.64		$	0.33
Net income (loss) per diluted share	$	0.69		$	0.63		$	0.32
Non-GAAP
Net income (loss) (U.S. GAAP) (1)	$	40,806		$	37,141		$	18,589
Non-GAAP adjustments:
Acquisition (gain) loss	—			—			(310		)
Restructuring charges	1,718			—			3,530
Research and development grant reimbursement	(470		)	—			—
ERP integration/IT transition costs	2,453			1,593			—
Stock-based compensation expense	1,534			4,417			2,206
Legal expenses/fines related to antitrust class actions	1,549			6,060			4,073
Net foreign exchange (gain) loss	(2,218		)	193			2,239
Amortization included in interest expense	450			406			696
Equity (income) loss from equity method investments	296			(64		)	(238		)
Plant start-up costs	305			1,361			—
(Gain) loss on write down and disposal of long-lived assets	788			312			(902		)
(Gain) loss on early extinguishment of debt	15,988			—			—
Income tax effect of non-GAAP adjustments	(91		)	(164		)	667
Adjusted net income (loss) (non-GAAP) (1)	$	63,108		$	51,255		$	30,550
Adjusted net income (loss) per basic share (non-GAAP)	$	1.09		$	0.89		$	0.54
Adjusted net income (loss) per diluted share (non-GAAP)	$	1.07		$	0.87		$	0.52
Weighted average shares outstanding:
Weighted average shares-basic	58,010			57,799			56,778
Weighted average shares-diluted	59,111			59,197			58,937

_________________

⁽¹⁾ Quarter ended December 31, 2017 adjusted due to the adoption of ASC 606.

9

Adjusted EBITDA

Adjusted EBITDA represents net income (loss) before net interest expense, income tax expense (benefit), and depreciation and amortization expense, adjusted to exclude certain items which are outlined in the quantitative reconciliation provided herein.  We use Adjusted EBITDA to monitor and evaluate our operating performance and to facilitate internal and external comparisons of the historical operating performance of our business.  We present Adjusted EBITDA as a supplemental measure of our performance and ability to service debt.  We also present Adjusted EBITDA because we believe such measure is frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry.

We believe Adjusted EBITDA is an appropriate supplemental measure of debt service capacity because cash expenditures on interest are, by definition, available to pay interest, and tax expense is inversely correlated to interest expense because tax expense goes down as deductible interest expense goes up; depreciation and amortization are non-cash charges. The other adjustments to arrive at Adjusted EBITDA are excluded in order to better reflect our continuing operations.

In evaluating Adjusted EBITDA, you should be aware that in the future we may incur expenses similar to the adjustments noted below.  Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these types of adjustments.  Adjusted EBITDA is not a measurement of our financial performance under U.S. GAAP and should not be considered as an alternative to net income, operating income or any other performance measures derived in accordance with U.S. GAAP or as an alternative to cash flow from operating activities as a measure of our liquidity.

Our Adjusted EBITDA measure has limitations as an analytical tool, and should not be considered in isolation or as a substitute for analysis of our results as reported under U.S. GAAP.  Some of these limitations are:

• it does not reflect our cash expenditures, future requirements for capital expenditures or contractual commitments;

• it does not reflect changes in, or cash requirements for, our working capital needs;

• it does not reflect any income tax expense or benefit, including any changes to income tax resulting from The Tax Cuts and Jobs Act enacted on December 22, 2017;

• it does not reflect the significant interest expense or the cash requirements necessary to service interest or principal payment on our debt;

• although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and our Adjusted EBITDA measure does not reflect any cash requirements for such replacements;

• it is not adjusted for all non-cash income or expense items that are reflected in our statements of cash flows;

• it does not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of our ongoing operations;

• it does not reflect limitations on or costs related to transferring earnings from our subsidiaries to us; and

• other companies in our industry may calculate this measure differently than we do, limiting its usefulness as a comparative measure.

Because of these limitations, Adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business or as a measure of cash that will be available to us to meet our obligations.  You should compensate for these limitations by relying primarily on our U.S. GAAP results and using Adjusted EBITDA as supplementary information.

10

The following table provides a reconciliation from U.S. GAAP net income (loss) to Adjusted EBITDA (amounts in thousands):

	Quarters Ended
	(Unaudited)
	December 31, 2018			September 30, 2018			December 31, 2017
Net income (loss) (U.S. GAAP)(1)	$	40,806		$	37,141		$	18,589
Non-GAAP adjustments:
Interest expense, net	3,908			6,912			7,155
Income tax expense (benefit) (1)	2,600			2,000			2,037
Depreciation and amortization(1)	12,763			12,545			11,353
EBITDA (non-GAAP)(1)	60,077			58,598			39,134
Excluding the following items:
Acquisition (gain) loss	—			—			(310		)
Restructuring charges	1,718			—			3,530
Research and development grant reimbursement	(470		)	—			—
ERP integration/IT transition costs	2,453			1,593			—
Stock-based compensation expense	1,534			4,417			2,206
Legal expenses/fines related to antitrust class actions	1,549			6,060			4,073
Net foreign exchange (gain) loss	(2,218		)	193			2,239
Equity (income) loss from equity method investments	296			(64		)	(238		)
(Gain) loss on early extinguishment of debt	15,988			—			—
Plant start-up costs	305			1,361			—
(Gain) loss on write down and disposal of long-lived assets	788			312			(902		)
Adjusted EBITDA (non-GAAP)	$	82,020		$	72,470		$	49,732

_________________

⁽¹⁾ Quarters ended September 30, 2017 adjusted due to the adoption of ASC 606.

11

EX-99.2

MAKING THE WORLD A BETTER, SAFER, MORE CONNECTED PLACE TO LIVE. Third Quarter Earnings Conference Call January 31, 2019 Quarter Ended December 31, 2018

Cautionary Statement Certain statements included herein contain forward-looking statements within the meaning of federal securities laws about the Company's financial condition and results of operations that are based on management's current expectations, estimates and projections about the markets, in which the Company operates, as well as management's beliefs and assumptions. Words such as "expects," "anticipates," "believes," "estimates" or other similar expressions and future or conditional verbs such as “will,” “should,” “would,” and “could” are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in, or implied by, such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's judgment only as of the date hereof. The Company undertakes no obligation to update publicly any of these forward-looking statements to reflect new information, future events or otherwise. Factors that may cause actual outcomes and results to differ materially from those expressed in, or implied by, these forward-looking statements include, but are not necessarily limited to the following: (i) adverse economic conditions could impact our ability to realize operating plans if the demand for our products declines, and such conditions could adversely affect our liquidity and ability to continue to operate and could cause a write down of long-lived assets or goodwill; (ii) an increase in the cost or a decrease in the availability of our principal or single-sourced purchased raw materials; (iii) changes in the competitive environment; (iv) uncertainty of the timing of customer product qualifications in heavily regulated industries; (v) economic, political, or regulatory changes in the countries in which we operate; (vi) difficulties, delays, or unexpected costs in completing the Company’s restructuring plans; (vii) acquisitions and other strategic transactions expose us to a variety of risks, including the ability to successfully integrate and maintain adequate internal controls over financial reporting in compliance with applicable regulations; (viii) our acquisition of TOKIN Corporation may not achieve all of the anticipated results; (ix) our business could be negatively impacted by increased regulatory scrutiny and litigation; (x) difficulties associated with retaining, attracting, and training effective employees and management; (xi) the need to develop innovative products to maintain customer relationships and offset potential price erosion in older products; (xii) exposure to claims alleging product defects; (xiii) the impact of laws and regulations that apply to our business, including those relating to environmental matters, data protection, cyber security and privacy; (xiv) the impact of international laws relating to trade, export controls and foreign corrupt practices; (xv) changes impacting international trade and corporate tax provisions related to the global manufacturing and sales of our products may have an adverse effect on our financial condition and results of operations; (xvi) volatility of financial and credit markets affecting our access to capital; (xvii) the need to reduce the total costs of our products to remain competitive; (xviii) potential limitation on the use of net operating losses to offset possible future taxable income; (xix) restrictions in our debt agreements that could limit our flexibility in operating our business; (xx) disruption to our information technology systems to function properly or control unauthorized access to our systems may cause business disruptions; (xxi) economic and demographic experience for pension and other post-retirement benefit plans could be less favorable than our assumptions; (xxii) fluctuation in distributor sales could adversely affect our results of operations; (xxiii) earthquakes and other natural disasters could disrupt our operations and have a material adverse effect on our financial condition and results of operations; and (xxiv) volatility in our stock price. 2

ASC 606 Adoption U.S. GAAP (Unaudited) KEMET implemented Accounting Standards Codification 606, Revenue from Contracts with Customers (“ASC 606”) as of April 1, 2018 (Fiscal Year 2019). As a result of the implementation of the new standard, the Company changed some of its accounting policies surrounding revenue recognition to be compliant with the new standard. The Company adopted the requirements of ASC 606 using the full retrospective method, which required us to restate each prior reporting period presented in our 10-Q's and 10-K's. As such, financial data from fiscal years 2018 and earlier included in this presentation have been adjusted from what was presented in prior fiscal years to conform with the requirements of ASC 606. For further information on these ASC 606 adjustments, refer to footnote 1 in the Company's fiscal year 2019 10-Q's. 3

Income Statement Highlights U.S. GAAP (Unaudited) For the Quarters Ended (Amounts in thousands, except percentages and per share data) Dec 2018 Sep 2018 Dec 2017 Net sales $ 350,175 $ 349,233 $ 306,576 Gross margin $ 123,750 $ 113,565 $ 92,288 Gross margin as a percentage of net sales 35.3% 32.5% 30.1% Selling, general and administrative $ 48,271 $ 52,258 $ 47,751 SG&A as a percentage of net sales 13.8% 15.0% 15.6% Operating income (loss) $ 61,616 $ 50,000 $ 32,002 Net income (loss) $ 40,806 $ 37,141 $ 18,589 Per basic and diluted share data: Net income (loss) per basic share $ 0.70 $ 0.64 $ 0.33 Net income (loss) per diluted share 0.69 0.63 0.32 Weighted avg. shares - basic 58,010 57,799 56,778 Weighted avg. shares - diluted 59,111 59,197 58,937 4

Income Statement Highlights Non-GAAP (Unaudited) For the Quarters Ended (Amounts in thousands, except percentages and per share data) Dec 2018 Sep 2018 Dec 2017 Net sales $ 350,175 $ 349,233 $ 306,576 Adjusted gross margin $ 124,721 $ 115,612 $ 92,690 Adjusted gross margin as a percentage of net sales 35.6% 33.1% 30.2% Adjusted selling, general and administrative $ 43,783 $ 45,278 $ 44,517 Adjusted SG&A as a percentage of net sales 12.5% 13.0% 14.5% Adjusted operating income (loss) $ 69,682 $ 59,423 $ 38,318 Adjusted net income (loss) $ 63,108 $ 51,255 $ 30,550 Adjusted EBITDA $ 82,020 $ 72,470 $ 49,732 Adjusted EBITDA margin as a percentage of net sales 23.4% 20.8% 16.2% Per share data: Adjusted net income (loss) - basic $ 1.09 $ 0.89 $ 0.54 Adjusted net income (loss) - diluted $ 1.07 $ 0.87 $ 0.52 Weighted avg. shares - basic 58,010 57,799 56,778 Weighted avg. shares - diluted 59,111 59,197 58,937 5

Financial Trends Quarterly Sales Summary U.S. GAAP (Unaudited) Net Sales 360 340 $349 $350 320 $328 $318 ) s n 300 $307 o i l l i M 280 ( $ 260 240 220 200 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 6

LTM Operating Income Margins U.S. GAAP (Unaudited) 14.0% 13.0% 12.5% 12.0% 11.0% 10.7% 10.0% 9.6% 9.4% 9.0% 9.2% 8.0% Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 7

LTM Adjusted EBITDA Margins Non-GAAP (Unaudited) 20% 19.3% 19% 18% 17.4% 17% 16.3% 16% 16.0% 15.8% 15% Dec Mar Jun Sep Dec 2017 2018 2018 2018 2018 8

Financial Highlights (Unaudited) (Amounts in millions) Dec 2018 Sep 2018 FX Impact Cash, cash equivalents $ 234.4 $ 263.0 $ 1.2 Capital expenditures $ 37.2 $ 24.5 Short-term debt $ 28.4 $ 20.6 Long-term debt 287.4 309.4 Debt (discount)/premium and issuance costs (10.1) (13.3) Total debt $ 305.7 $ 316.7 $ 8.6 Equity $ 538.4 $ 512.6 $ (5.2) Net working capital (1) $ 236.8 $ 232.0 $ (0.5) (1) Calculated as accounts receivable, net, plus inventories, net, less accounts payable. 9

Financial Trends Quarterly Cash and Cash Equivalents U.S. GAAP (Unaudited) $300 $270 $284 $287 $240 $263 $254 $245 $234 ) $210 $226 s $107 n $180 $107 o i l l i $150 M ( $120 $ $90 $110 $60 $87 $30 $0 Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 KEMET TOKIN (1) (1) TOKIN results exclude the EMD business which was sold on April 14, 2017. 10

Debt Trend - Q3 FY2019 (Unaudited) Total Debt Revolver Facility $400 $450 $350 $400 $328 $325 $320 $317 $305 $350 $300 $20 $21 $20 $21 $28 ) $300 ) s s $250 n n o $250 i o l i l l i l $200 i $200 M M ( ( $150 $308 $304 $300 $ $ $296 $277 $150 $100 $100 $50 $50 $75 $62 $0 $0 nt e n $0 u as w o B ra am g D Dec Mar Jun Sep Dec y in lit w ci ro a or 2017 2018 2018 2018 2018 F B LT Debt ST Debt Semi-Annual Principal Repayment ~ $12.5M 11 Debt Trend - Q3 FY2019 (Unaudited)

Net Debt (Unaudited) Net Debt (Debt less Cash on hand) ) s n o i l l i M $323 ( $ $278 $110 $78 $76 $71 $54 $44 $38 FY16 FY17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 12

Leverage Non-GAAP (Unaudited) Leverage (Debt/Adjusted EBITDA) 3.7 2.7 2.2 1.9 1.7 1.6 1.4 1.2 FY17 6/30/17 TTM 9/30/17 TTM 12/31/17 TTM FY 18 6/30/18 TTM 9/30/18 TTM 12/31/18 TTM 13

Adjusted Gross Margin - GAAP Reconciliation Solid Capacitors (Unaudited) For the Quarters Ended (Amounts in thousands, except percentages) Dec 2018 Sep 2018 Dec 2017 Net sales $ 238,683 $ 235,473 $ 195,049 Cost of sales 133,454 140,899 123,808 Gross margin (U.S. GAAP) 105,229 94,574 71,241 Gross margin as a percentage of net sales 44.1 % 40.2 % 36.5 % Non-GAAP adjustments: Stock-based compensation expense 415 447 256 Plant start-up costs 305 1,361 — Adjusted gross margin (non-GAAP) $ 105,949 $ 96,382 $ 71,497 Adjusted gross margin as a percentage of net sales 44.4 % 40.9 % 36.7 % 14

Adjusted Gross Margin - GAAP Reconciliation Film & Electrolytic (“F&E”) (Unaudited) For the Quarters Ended (Amounts in thousands, except percentages) Dec 2018 Sep 2018 Dec 2017 Net sales $ 50,171 $ 50,628 $ 51,468 Cost of sales 43,406 44,375 47,363 Gross margin (U.S. GAAP) 6,765 6,253 4,105 Gross margin as a percentage of net sales 13.5% 12.4% 8.0% Non-GAAP adjustments: Stock-based compensation expense 183 206 146 Adjusted gross margin (non-GAAP) $ 6,948 $ 6,459 $ 4,251 Adjusted gross margin as a percentage of net sales 13.8% 12.8% 8.3% 15

Adjusted Gross Margin - U.S. GAAP Electro-magnetic, Sensors & Actuators (“MSA”) (Unaudited) For the Quarters Ended (Amounts in thousands, except percentages) Dec 2018 Sep 2018 Dec 2017 Net sales $ 61,321 $ 63,132 $ 60,059 Cost of sales 49,565 50,394 43,117 Gross margin (U.S. GAAP) 11,756 12,738 16,942 Gross margin as a percentage of net sales 19.2% 20.2% 28.2% Non-GAAP adjustments: Stock-based compensation expense 68 33 — Adjusted gross margin (non-GAAP) $ 11,824 $ 12,771 $ 16,942 Adjusted gross margin as a percentage of net sales 19.3% 20.2% 28.2% 16

Sales Summary - Q3 FY2019 (Unaudited) INDUSTRY CHANNEL Def/Med 9% Telecom 14% Automotive 15% OEM Distributors Computer 42% 43% 21% Ind/Light 26% Consumer EMS 15% 15% REGION PRODUCT LINE MSA Americas 18% 26% APAC Tantalum 38% F&E 41% 14% EMEA JPKO 22% Ceramics 14% 27% 17

Global Distribution Q3 FY2019 Results (Unaudited) 18

Appendix

Adjusted Gross Margin Non-GAAP (Unaudited) For the Quarters Ended (Amounts in thousands, except percentages) Dec 2018 Sep 2018 Dec 2017 Net Sales $ 350,175 $ 349,233 $ 306,576 Cost of sales 226,425 235,668 214,288 Gross Margin (U.S. GAAP) 123,750 113,565 92,288 Gross margin as a percentage of net sales 35.3% 32.5% 30.1% Non-GAAP adjustments: Stock-based compensation expense 666 686 402 Plant start-up costs 305 1,361 — Adjusted gross margin (non-GAAP) $ 124,721 $ 115,612 $ 92,690 Adjusted gross margin as a percentage of net sales 35.6% 33.1% 30.2% 20

Adjusted Selling, General & Administrative Expenses Non-GAAP (Unaudited) For the Quarters Ended (Amounts in thousands, except percentages) Dec 2018 Sep 2018 Dec 2017 Net sales $ 350,175 $ 349,233 $ 306,576 Selling, general and administrative expenses (U.S. GAAP) $ 48,271 $ 52,258 $ 47,751 Selling, general, and administrative as a percentage of net sales 13.8% 15.0% 15.6% Less non-GAAP adjustments: ERP integration/IT transition costs 2,453 1,593 — Stock-based compensation expense 767 3,647 1,752 Legal expenses/fines related to antitrust class actions 1,268 1,740 1,482 Adjusted selling, general and administrative expenses (non-GAAP) $ 43,783 $ 45,278 $ 44,517 Adjusted selling, general, and administrative as a percentage of net sales 12.5% 13.0% 14.5% 21

Adjusted Operating Income (Loss) Non-GAAP (Unaudited) For the Quarters Ended (Amounts in thousands) Dec 2018 Sep 2018 Dec 2017 Operating income (loss) (U.S. GAAP) $ 61,616 $ 50,000 $ 32,002 Non-GAAP adjustments: Restructuring charges 1,718 — 3,530 Legal expenses/fines related to antitrust class actions 1,268 1,740 1,482 Stock-based compensation expense 1,534 4,417 2,206 (Gain) loss on write down and disposal of long-lived assets 788 312 (902) ERP integration/IT transition costs 2,453 1,593 — Plant start-up costs 305 1,361 — Adjusted operating income (loss) (non-GAAP) $ 69,682 $ 59,423 $ 38,318 22

Adjusted Net Income (Loss) Non-GAAP (Unaudited) For the Quarters Ended (Amounts in thousands, except per share data) Dec 2018 Sep 2018 Dec 2017 Net income (loss) (U.S. GAAP) $ 40,806 $ 37,141 $ 18,589 Non-GAAP adjustments: Equity (income) loss from equity method investments 296 (64) (238) Acquisition (gain) loss — — (310) Net foreign exchange (gain) loss (2,218) 193 2,239 Restructuring charges 1,718 — 3,530 Research and development grant reimbursement (470) — — Legal expenses/fines related to antitrust class actions 1,549 6,060 4,073 Stock-based compensation expense 1,534 4,417 2,206 (Gain) loss on early extinguishment of debt 15,988 — — Amortization included in interest expense 450 406 696 Income tax effect of non-U.S. GAAP adjustments (1) (91) (164) 667 (Gain) loss on write down and disposal of long-lived assets 788 312 (902) ERP integration/IT transition costs 2,453 1,593 — Plant start-up costs 305 1,361 — Adjusted net income (loss) (non-GAAP) $ 63,108 $ 51,255 $ 30,550 Adjusted net income (loss) per share - basic $ 1.09 $ 0.89 $ 0.54 Adjusted net income (loss) per share - diluted $ 1.07 $ 0.87 $ 0.52 Adjusted EBITDA (non-GAAP) $ 82,020 $ 72,470 $ 49,732 Weighted avg. shares - basic 58,010 57,799 56,778 Weighted avg. shares - diluted 59,111 59,197 58,937 (1) The income tax effect of the excluded items is calculated by applying the applicable jurisdictional income tax rate, considering the deferred tax valuation for each applicable jurisdiction. 23

Adjusted EBITDA Reconciliation Non-GAAP (Unaudited) For the Quarters Ended (Amounts in thousands) Dec 2018 Sep 2018 Dec 2017 Net income (loss) (U.S. GAAP) $ 40,806 $ 37,141 $ 18,589 Non-GAAP adjustments: Interest expense (income), net 3,908 6,912 7,155 Income tax expense (benefit) 2,600 2,000 2,037 Depreciation and amortization 12,763 12,545 11,353 EBITDA (non-GAAP) 60,077 58,598 39,134 Excluding the following items: Equity (income) loss from equity method investments 296 (64) (238) Acquisition (gain) loss — — (310) Net foreign exchange (gain) loss (2,218) 193 2,239 Restructuring charges 1,718 — 3,530 Research and development grant reimbursement (470) — — Legal expenses/fines related to antitrust class actions 1,549 6,060 4,073 Stock-based compensation expense 1,534 4,417 2,206 (Gain) loss on early extinguishment of debt 15,988 — — (Gain) loss on write down and disposal of long-lived assets 788 312 (902) Plant start-up costs 305 1,361 — ERP integration/IT transition costs 2,453 1,593 — Adjusted EBITDA (non-GAAP) $ 82,020 $ 72,470 $ 49,732 24

Adjusted EBITDA Reconciliation Non-GAAP (Unaudited) Quarters Ended LTM (Amounts in thousands, except percentages) Mar 2017 Jun 2017 Sep 2017 Dec 2017 Dec 2017 Net Sales $ 197,066 $ 273,946 $ 301,568 $ 306,576 $ 1,079,156 Net income (loss) (U.S. GAAP) 52,082 220,439 12,819 18,589 303,929 Non-GAAP adjustments: Income tax expense (benefit) (146) 1,140 2,864 2,037 5,895 Interest expense, net 9,994 10,894 7,270 7,155 35,313 Depreciation and amortization 10,180 12,459 13,554 11,353 47,546 EBITDA (non-GAAP) 72,110 244,932 36,507 39,134 392,683 Excluding the following items: Change in value of TOKIN options (14,200) — — — (14,200) Equity (income) loss from equity method investments (41,372) (75,417) (224) (238) (117,251) Acquisition (gain) loss — (135,588) (1,285) (310) (137,183) Restructuring charges 1,087 1,613 1,393 3,530 7,623 ERP integration costs / IT transition costs 1,760 — — — 1,760 Stock-based compensation expense 1,249 1,101 1,530 2,206 6,086 Legal expenses related to antitrust class actions 406 1,141 10,327 4,073 15,947 Net foreign exchange (gain) loss 1,507 5,043 1,891 2,239 10,680 TOKIN investment-related expenses 497 — — — 497 (Gain) loss on write down and disposal of long-lived assets 4,171 19 (39) (902) 3,249 (Gain) loss on early extinguishment of debt — 486 — — 486 Adjusted EBITDA (non-GAAP) $ 27,215 $ 43,330 $ 50,100 $ 49,732 $ 170,377 Adjusted EBITDA Margin (non-GAAP) 13.8% 15.8% 16.6% 16.2% 15.8% Total Debt balance as of December 31, 2017 328,162 Leverage ratio (Debt/Adjusted EBITDA) 1.9 25

Adjusted EBITDA Reconciliation Non-GAAP (Unaudited) Fiscal Year (Amounts in thousands, except percentages) 2016 2017 2018 Net Sales $ 734,823 $ 757,338 $ 1,200,181 Net income (loss) (U.S. GAAP) (53,629) 47,157 254,127 Non-GAAP adjustments: Income tax expense (benefit) 6,006 4,294 9,132 Interest expense, net 39,591 39,731 32,073 Depreciation and amortization 39,016 38,151 50,661 EBITDA (non-GAAP) 30,984 129,333 345,993 Excluding the following items: Change in value of TOKIN options 26,300 (10,700) — Equity (income) loss from equity method investments 16,406 (41,643) (76,192) Acquisition (gain) loss — — (130,880) Restructuring charges 4,178 5,404 14,843 ERP integration costs / IT transition costs 5,677 7,045 80 Stock-based compensation expense 4,774 4,720 7,657 Legal expenses related to antitrust class actions 3,041 2,640 16,636 Net foreign exchange (gain) loss (3,036) (3,758) 13,145 TOKIN investment-related expenses 900 1,101 — Plant start-up costs 861 427 929 Plant shut-down costs 372 — — (Gain) loss on write down and sale of long-lived assets 375 10,671 (992) Pension plan adjustment 312 — — (Gain) loss on early extinguishment of debt — — 486 Adjusted EBITDA (non-GAAP) $ 91,144 $ 105,240 $ 191,705 Adjusted EBITDA Margin 12.4% 13.9% 16.0% Total Debt as of March 31, $ 387,833 $ 388,211 $ 324,623 26 Leverage ratio (Debt/Adjusted EBITDA) $ 4.3 $ 3.7 $ 1.7

Adjusted EBITDA Reconciliation Non-GAAP (Unaudited) LTM (Amounts in thousands, except percentages) Sep 2017 Dec 2017 Mar 2018 Jun 2018 Jun 2018 Net Sales $ 301,568 $ 306,576 $ 318,091 $ 327,616 $ 1,253,851 Net income (loss) (U.S. GAAP) 12,819 18,589 2,280 35,220 68,908 Non-GAAP adjustments: Income tax expense (benefit) 2,864 2,037 3,091 4,600 12,592 Interest expense, net 7,270 7,155 6,754 6,658 27,837 Depreciation and amortization 13,554 11,353 13,295 13,097 51,299 EBITDA (non-GAAP) 36,507 39,134 25,420 59,575 160,636 Excluding the following items: Equity (income) loss from equity method investments (224) (238) (313) 69 (706) Acquisition (gain) loss (1,285) (310) 6,303 — 4,708 Restructuring charges 1,393 3,530 8,307 (96) 13,134 Research and development grant reimbursement — — — (4,087) (4,087) ERP integration costs / IT transition costs — — 80 1,650 1,730 Stock-based compensation expense 1,530 2,206 2,820 4,060 10,616 Legal expenses related to antitrust class actions 10,327 4,073 1,095 1,248 16,743 Net foreign exchange (gain) loss 1,891 2,239 3,972 (7,521) 581 Plant start-up costs — — 929 753 1,682 (Gain) loss on write down and disposal of long-lived assets (39) (902) (70) 511 (500) Adjusted EBITDA (non-GAAP) $ 50,100 $ 49,732 $ 48,543 $ 56,162 $ 204,537 Adjusted EBITDA Margin (non-GAAP) 16.6% 16.2% 15.3% 17.1% 16.3% Total Debt balance as of June 30, 2018 320,223 Leverage ratio (Debt/Adjusted EBITDA) 1.6 27

Adjusted EBITDA Reconciliation Non-GAAP (Unaudited) LTM (Amounts in thousands, except percentages) Dec 2017 Mar 2018 Jun 2018 Sep 2018 Sep 2018 Net Sales $ 306,576 $ 318,091 $ 327,616 $ 349,233 $ 1,301,516 Net income (loss) (U.S. GAAP) 18,589 2,280 35,220 37,141 93,230 Non-GAAP adjustments: Income tax expense (benefit) 2,037 3,091 4,600 2,000 11,728 Interest expense, net 7,155 6,754 6,658 6,912 27,479 Depreciation and amortization 11,353 13,295 13,097 12,545 50,290 EBITDA (non-GAAP) 39,134 25,420 59,575 58,598 182,727 Excluding the following items: Equity (income) loss from equity method investments (238) (313) 69 (64) (546) Acquisition (gain) loss (310) 6,303 — — 5,993 Restructuring charges 3,530 8,307 (96) — 11,741 Research and development grant reimbursement — — (4,087) — (4,087) ERP integration costs / IT transition costs — 80 1,650 1,593 3,323 Stock-based compensation expense 2,206 2,820 4,060 4,417 13,503 Legal expenses related to antitrust class actions 4,073 1,095 1,248 6,060 12,476 Net foreign exchange (gain) loss 2,239 3,972 (7,521) 193 (1,117) Plant start-up costs — 929 753 1,361 3,043 (Gain) loss on write down and disposal of long-lived assets (902) (70) 511 312 (149) Adjusted EBITDA (non-GAAP) $ 49,732 $ 48,543 $ 56,162 $ 72,470 $ 226,907 Adjusted EBITDA Margin (non-GAAP) 16.2% 15.3% 17.1% 20.8% 17.4% Total Debt balance as of September 30, 2018 316,636 Leverage ratio (Debt/Adjusted EBITDA) 1.4 28

Adjusted EBITDA Reconciliation Non-GAAP (Unaudited) LTM (Amounts in thousands, except percentages) Mar 2018 Jun 2018 Sep 2018 Dec 2018 Dec 2018 Net Sales $ 318,091 $ 327,616 $ 349,233 $ 350,175 $ 1,345,115 Net income (loss) (U.S. GAAP) 2,280 35,220 37,141 40,806 115,447 Non-GAAP adjustments: Income tax expense (benefit) 3,091 4,600 2,000 2,600 12,291 Interest expense, net 6,754 6,658 6,912 3,908 24,232 Depreciation and amortization 13,295 13,097 12,545 12,763 51,700 EBITDA (non-GAAP) 25,420 59,575 58,598 60,077 203,670 Excluding the following items: Equity (income) loss from equity method investments (313) 69 (64) 296 (12) Acquisition (gain) loss 6,303 — — — 6,303 Restructuring charges 8,307 (96) — 1,718 9,929 Research and development grant reimbursement — (4,087) — (470) (4,557) ERP integration costs / IT transition costs 80 1,650 1,593 2,453 5,776 Stock-based compensation expense 2,820 4,060 4,417 1,534 12,831 Legal expenses related to antitrust class actions 1,095 1,248 6,060 1,549 9,952 Net foreign exchange (gain) loss 3,972 (7,521) 193 (2,218) (5,574) Plant start-up costs 929 753 1,361 305 3,348 (Gain) loss on write down and disposal of long-lived assets (70) 511 312 788 1,541 (Gain) loss on early extinguishment of debt — — — 15,988 15,988 Adjusted EBITDA (non-GAAP) $ 48,543 $ 56,162 $ 72,470 $ 82,020 $ 259,195 Adjusted EBITDA Margin (non-GAAP) 15.3% 17.1% 20.8% 23.4% 19.3% Total Debt balance as of December 31, 2018 305,676 Leverage ratio (Debt/Adjusted EBITDA) 1.2 29

Non-GAAP Financial Measures Non-GAAP Financial Measures Included in this presentation are certain non-GAAP financial measures designed to complement the financial information presented in accordance with generally accepted accounting principles in the United States of America because management believes such measures are useful to investors for the reasons described below. Adjusted gross margin Adjusted gross margin represents net sales less cost of sales excluding adjustments which are outlined in the quantitative reconciliation provided earlier in this presentation. Management uses Adjusted gross margin to facilitate our analysis and understanding of our business operations by excluding the items outlined in the quantitative reconciliation provided earlier in this presentation which might otherwise make comparisons of our ongoing business with prior periods more difficult and obscure trends in ongoing operations. The Company believes that Adjusted gross margin is useful to investors because it provides a supplemental way to understand the underlying operating performance of the Company. Adjusted gross margin should not be considered as an alternative to gross margin or any other performance measure derived in accordance with GAAP. Adjusted selling, general and administrative expenses Adjusted selling, general and administrative expenses represents selling, general and administrative expenses excluding adjustments which are outlined in the quantitative reconciliation provided earlier in this presentation. Management uses Adjusted selling, general and administrative expenses to facilitate our analysis and understanding of our business operations by excluding the items outlined in the quantitative reconciliation provided earlier in this presentation which might otherwise make comparisons of our ongoing business with prior periods more difficult and obscure trends in ongoing operations. The Company believes that Adjusted selling, general and administrative expenses is useful to investors because it provides a supplemental way to understand the underlying operating performance of the Company. Adjusted selling, general and administrative expenses should not be considered as an alternative to selling, general and administrative expenses or any other performance measure derived in accordance with GAAP. Adjusted operating income (loss) Adjusted operating income (loss) represents operating income (loss), excluding adjustments which are outlined in the quantitative reconciliation provided earlier in this presentation. Management uses Adjusted operating income (loss) to facilitate our analysis and understanding of our business operations by excluding the items outlined in the quantitative reconciliation provided earlier in this presentation which might otherwise make comparisons of our ongoing business with prior periods more difficult and obscure trends in ongoing operations. The Company believes that Adjusted operating income (loss) is useful to investors to provide a supplemental way to understand the underlying operating performance of the Company and allows investors to monitor and understand changes in our ability to generate income from ongoing business operations. Adjusted operating 30 income (loss) should not be considered as an alternative to operating income (loss) or any other performance measure derived in accordance with GAAP.

Non-GAAP Financial Measures Continued Adjusted net income (loss) and Adjusted EPS Adjusted net income (loss) and Adjusted EPS represent net income (loss) and EPS, excluding adjustments which are more specifically outlined in the quantitative reconciliation provided earlier in this presentation. Management uses Adjusted net income (loss) and Adjusted EPS to evaluate the Company's operating performance by excluding the items outlined in the quantitative reconciliation provided earlier in this presentation which might otherwise make comparisons of our ongoing business with prior periods more difficult and obscure trends in ongoing operations. The Company believes that Adjusted net income (loss) and Adjusted EPS are useful to investors because they provide a supplemental way to understand the underlying operating performance of the Company and allows investors to monitor and understand changes in our ability to generate income from ongoing business operations. Adjusted net income (loss) and Adjusted EPS should not be considered as alternatives to net income (loss), operating income (loss) or any other performance measures derived in accordance with GAAP. Adjusted EBITDA Adjusted EBITDA represents net income (loss) before income tax expense (benefit), interest expense (benefit), net, and depreciation and amortization expense, excluding adjustments which are more specifically outlined in the quantitative reconciliation provided earlier in this presentation. We present Adjusted EBITDA as a supplemental measure of our performance and ability to service debt. We also present Adjusted EBITDA because we believe such measure is frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry.   We believe Adjusted EBITDA is an appropriate supplemental measure of debt service capacity, because cash expenditures on interest are, by definition, available to pay interest, and tax expense is inversely correlated to interest expense because tax expense goes down as deductible interest expense goes up; depreciation and amortization are non-cash charges. The other items excluded from Adjusted EBITDA are excluded in order to better reflect our continuing operations.   In evaluating Adjusted EBITDA, you should be aware that in the future we may incur expenses similar to the adjustments in this presentation. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these types of adjustments. Adjusted EBITDA is not a measurement of our financial performance under GAAP and should not be considered as an alternative to net income (loss), operating income (loss) or any other performance measures derived in accordance with GAAP or as an alternative to cash flow from operating activities as a measure of our liquidity. 31

Non-GAAP Financial Measures Continued Our Adjusted EBITDA measure has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are: • it does not reflect our cash expenditures, future requirements for capital expenditures or contractual commitments; • it does not reflect changes in, or cash requirements for, our working capital needs; • it does not reflect any income tax expense or benefit, including any changes to income taxes resulting from The Tax Cuts and Jobs Act enacted on December 22, 2017; • it does not reflect the significant interest expense or the cash requirements necessary to service interest or principal payment on our debt; • although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and our Adjusted EBITDA measure does not reflect any cash requirements for such replacements; • it is not adjusted for all non-cash income or expense items that are reflected in our statements of cash flows; • it does not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of our ongoing operations; • it does not reflect limitations on or costs related to transferring earnings from our subsidiaries to us; and • other companies in our industry may calculate this measure differently than we do, limiting its usefulness as a comparative measure. Because of these limitations, Adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business or as a measure of cash that will be available to us to meet our obligations. You should 32 compensate for these limitations by relying primarily on our GAAP results and using Adjusted EBITDA only supplementary.